Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

DuPont Celebrates Official Opening of Industrial Biosciences’ Global Business Headquarters in Wilmington, Delaware
  • USA - English


News provided by

DuPont

Jun 08, 2018, 12:00 ET

Share this article

Share toX

Share this article

Share toX


WILMINGTON, Del. (PRWEB) June 08, 2018 -- DuPont Industrial Biosciences (IB) officially opened the doors of its renovated global business headquarters today in Wilmington, Delaware. This new center of technological innovation, known as Building E353, is part of DuPont’s Experimental Station – the breeding ground for numerous paradigm-shifting technologies over the decades from nylon to DuPont™ Kevlar® to Lycra® to IB’s own renewably sourced Sorona®.

For all assets related to this announcement, visit: http://biosciences.dupont.com/grandopening.

This state-of-the-art facility represents DuPont’s commitment to Delaware, and with the brilliant men and women who work there every day, the possibilities are endless.

Post this

The researchers, business teams and cutting-edge laboratories at the new E353 facility will continue the tradition of innovation and scientific advancement on the historic Experimental Station site, while fostering the next wave of progress in industrial biosciences that results in better and more sustainable products and processes for customers across the globe.

“At this new facility, we have hundreds of people working toward a more sustainable future by innovating biobased solutions that are better, safer and more renewable. These technologies go into products that are used in everyday life,” said William Feehery, president of DuPont Industrial Biosciences. “The redesigned and upgraded laboratories and office spaces are incubators for some of DuPont’s most groundbreaking work.”

The revitalization of Building E353 is part of a more than $200 million investment in the Experimental Station campus, which began in 2016 and encompasses about 50 buildings, with over 2 million square feet of space. The E353 refurbishment focused on modernization, consolidation and advanced capabilities, including:

• Advanced, high-throughput instrumentation, state-of-the-art bioinformatics and genomics capabilities to accelerate discovery and applications research.
• Cutting-edge genome editing capabilities using CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) to accelerate microbial production host development.
• Microbiological labs to evaluate tailored animal health solutions and to conduct microbiome science for probiotics product development.
• Highly leveraged fermentation labs to advance “cell factory” end-to-end development and commercialization.
• Leading-edge chemistry and bioprocess science and engineering capabilities to establish high-performance biomaterials platforms.

“This building and the state-of-the-art research performed by talented and diverse employees builds on DuPont’s legacy of discovery and innovation,” said Marc Doyle, COO of DowDuPont Specialty Products Division. “As we enter our next phase of growth, we are excited that the Specialty Products Division will carry the DuPont name and continue to call Delaware home. The new DuPont will be a premier innovation-driven leader delivering highly specialized products and solutions that transform industries and improve everyday life.”

“DuPont has a long history of scientific discovery in Delaware,” said Delaware Governor John Carney. “We’re proud to help announce the opening of the DuPont Industrial Biosciences Global Headquarters. The Experimental Station remains a vital hub for science and innovation, and we’re working together on campus to promote early-stage companies at the Delaware Innovation Space. The fact is Delaware remains a great place for companies of any size to put down roots, grow and create jobs. We look forward to our continued work together with DowDuPont.”

“DuPont continues to build its centuries-old legacy of researching and creating new products in Delaware,” said U.S. Senator Tom Carper. “This facility will help keep and attract good-paying jobs here in the First State.”

“From stain-busting enzymes to next-generation biofuels, the products being developed inside the Industrial Biosciences building are exciting for DuPont, Delaware, and the world,” said U.S. Senator Chris Coons. “This state-of-the-art facility represents DuPont’s commitment to Delaware, and with the brilliant men and women who work there every day, the possibilities are endless.”

“DuPont has once again chosen to expand its Delaware roots and tradition of scientific advancement with the official opening of the Industrial Biosciences global business headquarters in Wilmington. The company’s continued investment in the First State will provide hundreds of good paying jobs and drive economic activity throughout the region,” said Congresswoman Lisa Blunt Rochester. “Equipped with state-of-the-art technologies and cutting-edge laboratories, DuPont’s new facility will allow its scientists and researchers to continue their work on ground-breaking, sustainable and renewable products used in everyday life. I am looking forward to the next generation of life-changing, innovative solutions to come out of DuPont's recently renovated and modernized headquarters.”

“We are collaborating with DuPont to win the future,” said New Castle County Executive Matt Meyer. “We win the future when DuPont Industrial Biosciences chooses to construct its state-of-the-art headquarters right here in New Castle County. For generations to come, Delawareans will be developing innovative, life-saving products for the world at this site.”

About DuPont Industrial Biosciences

DuPont Industrial Biosciences, A DowDuPont Specialty Products Division business, works with customers across a wide range of industries to make products and industrial processes more efficient and sustainable. Through a unique combination of agriculture, biotechnology, chemistry and material science capabilities, we advance market-driven, biobased solutions to meet the needs of a growing population, while protecting our environment for future generations. For updates about how DuPont Industrial Biosciences is helping customers deliver cost-effective products with superior performance and sustainability, follow @DuPontBiobased on Twitter, find us on LinkedIn, or visit our website at http://biosciences.dupont.com.

About DowDuPont Specialty Products Division

DowDuPont Specialty Products, a division of DowDuPont (NYSE: DWDP), is a global innovation leader with highly differentiated materials, ingredients and capabilities that help transform industries and everyday life. DowDuPont Specialty Products includes five technology-driven businesses: Electronic Technologies, Industrial Biosciences, Nutrition & Health, Protective Solutions and Sustainable Solutions. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver real-world products and smart solutions across multiple high-value markets. DowDuPont intends to separate the Specialty Products division into an independent, publicly traded company. More information can be found at http://www.dow-dupont.com.

# # #

6/8/18

The DuPont Oval logo, DuPont™ and all products, unless otherwise noted, denoted with ™, ℠or ® are trademarks or registered trademarks of E.I. du Pont de Nemours and Company or its affiliates.

Wendy Rosen, DuPont, +1-650-284-6429, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.